These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2962058)

  • 21. [Clinical aspects of polycystic syndrome of the ovary: the behavior of salivary testosterone and estrone].
    Piccione E; Baschieri L; Giacomello F; Sesti F
    Clin Ter; 1984 Jul; 110(2):119-22. PubMed ID: 6237852
    [No Abstract]   [Full Text] [Related]  

  • 22. The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics.
    Russell JB; Mitchell D; Musey PI; Collins DC
    Obstet Gynecol; 1984 Apr; 63(4):452-6. PubMed ID: 6322078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Etiopathogenesis of the polycystic ovary syndrome].
    Sciarra F; Toscano V; Tosti-Croce C
    Minerva Endocrinol; 1987; 12(3):183-90. PubMed ID: 3116379
    [No Abstract]   [Full Text] [Related]  

  • 24. [Exploration of the ovarian steroid biosynthetic pathways in the Stein-Leventhal syndrome. Stimulation "in vitro" with HMG].
    Bruni V; Sbiroli C; Forleo R
    Riv Ostet Ginecol; 1967 Feb; 22():Suppl:53-66. PubMed ID: 5601268
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of the surgical treatment of sclerocystic ovary syndrome on the gonadotropic function of the pituitary gland].
    Dobrotina AF; Kachalina TS
    Akush Ginekol (Mosk); 1982 Nov; (11):18-20. PubMed ID: 6818862
    [No Abstract]   [Full Text] [Related]  

  • 26. Physiological and biochemical role of luteinizing hormone-releasing factor (LH-RF) and follicle stimulating hormone releasing factor (FSH-RF).
    McCann SM; Watanabe S; Dhariwal AP
    Arch Anat Microsc Morphol Exp; 1967; 56(3):486-503. PubMed ID: 4882501
    [No Abstract]   [Full Text] [Related]  

  • 27. Galactorrhea and hyperprolactinemia during treatment of polycystic ovary syndrome.
    Wortsman J; Hirschowitz JS
    Obstet Gynecol; 1980 Apr; 55(4):460-3. PubMed ID: 6768040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relation between hyperprolactinemia and polycystic ovary syndrome].
    Hámori M; Szendei G; Kovács I; Somos P
    Zentralbl Gynakol; 1987; 109(8):481-6. PubMed ID: 3111126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for the hypothalamic origin of the polycystic ovary syndrome.
    Wortsman J; Singh KB; Murphy J
    Obstet Gynecol; 1981 Aug; 58(2):137-41. PubMed ID: 6454866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and pathogenesis of polycystic ovary syndrome].
    Lin SQ
    Zhonghua Yi Xue Za Zhi; 1983 Jul; 63(7):447-52. PubMed ID: 6416651
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of follicle-stimulating and luteinizing hormones in the etiopathogenesis of the Stein-Leventhal syndrome].
    Spasov S; Milanov S; Dokumov S; Dashev G
    Akush Ginekol (Sofiia); 1975; 14(4):289-92. PubMed ID: 1217664
    [No Abstract]   [Full Text] [Related]  

  • 32. Endocrine patterns in polycystic ovarian disease.
    Riley GM; Evans TN
    Int J Fertil; 1965; 10(4):349-58. PubMed ID: 5842644
    [No Abstract]   [Full Text] [Related]  

  • 33. Some new thoughts on the Stein-Leventhal syndrome.
    Greenblatt RB; Mahesh VB
    J Reprod Med; 1974 Sep; 13(3):85-8. PubMed ID: 4415831
    [No Abstract]   [Full Text] [Related]  

  • 34. Pituitary response to synthetic LH-RH in Stein-Leventhal syndrome and functional amenorrhea.
    Zárate A; Canales ES; De la Cruz A; Soria J; Schally AV
    Obstet Gynecol; 1973 Jun; 41(6):803-8. PubMed ID: 4575303
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.
    Seibel MM; Oskowitz S; Kamrava M; Taymor ML
    Obstet Gynecol; 1984 Aug; 64(2):213-9. PubMed ID: 6234484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuroendocrine regulation of the secretion of gonadotropins in the polycystic ovary syndrome].
    Massobrio M; Guidetti D
    Minerva Endocrinol; 1987; 12(3):191-4. PubMed ID: 3116380
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular mysteries of polycystic ovary syndrome.
    Strauss JF; Dunaif A
    Mol Endocrinol; 1999 Jun; 13(6):800-5. PubMed ID: 10379878
    [No Abstract]   [Full Text] [Related]  

  • 39. [Physiopathology of the secretion of prolactin in ovarian polycystosis].
    Falaschi P; Rosa M; Proietti A; Di Cesare G; Canfalone GC
    Minerva Endocrinol; 1987; 12(3):195-8. PubMed ID: 2821372
    [No Abstract]   [Full Text] [Related]  

  • 40. Latest clue to exercise-induced amenorrhea.
    Ziporyn T
    JAMA; 1984 Sep; 252(10):1258-9, 1263. PubMed ID: 6088816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.